Global Ophthalmic Devices Market report published by Accurize Market Research forecast that the global market is expected to reach $29 billion by 2025; growing at a CAGR of 6.2% from 2017 to 2025. By geography, Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.

Request Sample:
https://www.accurizemarketresearch.com/report/ophthalmic-devices-market/sample-request

Rapid growth in the geriatric population and associated rise in the prevalence of eye ailments, technological advancements in ophthalmic devices and growing healthcare expenses to drive the growth of the market

Rapid growth in the geriatric population and associated rise in the prevalence of eye ailments, technological advancements in ophthalmic devices and growing healthcare expenses fuel the demand for the global ophthalmic devices market. Furthermore, increasing government initiatives to control visual deficiency, and increasing adoption of contact lenses and spectacles also boosts the growth of the market.

Market Segmentation

The global ophthalmic devices market has been bifurcated on the basis of technology, and geography. Technology segment is segmented into contact lenses market, cataract surgery market, other surgical devices market and ophthalmology diagnostic and imaging market. By geography the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

Ask for customization:
https://www.accurizemarketresearch.com/report/ophthalmic-devices-market/ask-for-customization

Top players in the market

The key players operational in the market includes Abbott Medical Optics, Alcon, Allergan, Avedro Inc., Bausch & Lomb, Bio-Tissue Inc., Carl Zeiss MeditecAG, Coopervision, Dutch Ophthalmic Research Center International BV, Ellex Medical Lasers, Eyenuk Inc., Glaukos, Heidelberg Engineering GMBH, Hoya Corp., Ioptima Ltd., Iridex Corp., Johnson & Johnson, Lenstec Inc., Lumenis, Nidek Inc., Optovue Inc., Oasis Medical Inc., Quantel Medical, Sav-IolSA, Shanghai Haohai Biological Technology Co. Ltd., Sight Sciences Inc., Softcare Solution Inc., Staar Surgical, Tearscience Inc., Topcon, Vasoptic Medical Inc. and Ziemer Ophthalmic Systems AG others.